Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 219,000 | -52,000 | 996,000 | 747,000 | 7,000 |
| Depreciation Amortization | 329,000 | 320,000 | 295,000 | 286,000 | 300,000 |
| Income taxes - deferred | -120,000 | -165,000 | 23,000 | 83,000 | -111,000 |
| Accounts receivable | 175,000 | 191,000 | 47,000 | -88,000 | 5,000 |
| Accounts payable and accrued liabilities | 55,000 | -169,000 | 64,000 | -172,000 | 332,000 |
| Other Working Capital | 356,000 | 138,000 | -173,000 | -406,000 | 484,000 |
| Other Operating Activity | -207,000 | 387,000 | -112,000 | 190,000 | -423,000 |
| Operating Cash Flow | $807,000 | $650,000 | $1,140,000 | $640,000 | $594,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -267,000 | -481,000 | -498,000 | -411,000 | -338,000 |
| Net Acquisitions | 5,000 | -1,000 | 9,000 | 39,000 | 708,000 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -1,000 |
| Other Investing Activity | 28,000 | -1,000 | 2,000 | 2,000 | -12,000 |
| Investing Cash Flow | $-234,000 | $-483,000 | $-487,000 | $-370,000 | $357,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 12,000 | 128,000 | N/A | N/A | N/A |
| Debt Issued | 1,100,000 | 150,000 | 520,000 | 495,000 | N/A |
| Debt Repayment | -1,265,000 | -172,000 | -708,000 | -28,000 | -381,000 |
| Common Stock Issued | 16,000 | 9,000 | 16,000 | 31,000 | 11,000 |
| Common Stock Repurchased | N/A | -322,000 | -644,000 | -106,000 | N/A |
| Dividend Paid | -164,000 | -164,000 | -148,000 | -22,000 | -22,000 |
| Other Financing Activity | -148,000 | -48,000 | -29,000 | -18,000 | -4,000 |
| Financing Cash Flow | $-449,000 | $-419,000 | $-993,000 | $352,000 | $-396,000 |
| Exchange Rate Effect | 38,000 | -6,000 | -15,000 | 32,000 | -19,000 |
| Beginning Cash Position | 943,000 | 1,201,000 | 1,556,000 | 902,000 | 366,000 |
| End Cash Position | 1,105,000 | 943,000 | 1,201,000 | 1,556,000 | 902,000 |
| Net Cash Flow | $162,000 | $-258,000 | $-355,000 | $654,000 | $536,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 807,000 | 650,000 | 1,140,000 | 640,000 | 594,000 |
| Capital Expenditure | -267,000 | -481,000 | -498,000 | -411,000 | -338,000 |
| Free Cash Flow | 540,000 | 169,000 | 642,000 | 229,000 | 256,000 |